PREVISICO_LIMITED - Accounts


Company Registration No. 11663974 (England and Wales)
PREVISICO LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 30 NOVEMBER 2019
PAGES FOR FILING WITH REGISTRAR
PREVISICO LIMITED
CONTENTS
Page
Balance sheet
1 - 2
Statement of changes in equity
3
Notes to the financial statements
4 - 8
PREVISICO LIMITED
BALANCE SHEET
AS AT 30 NOVEMBER 2019
30 November 2019
- 1 -
2019
Notes
£
£
Fixed assets
Tangible assets
3
4,434
Current assets
Debtors
4
48,912
Cash at bank and in hand
291,655
340,567
Creditors: amounts falling due within one year
5
(54,035)
Net current assets
286,532
Total assets less current liabilities
290,966
Creditors: amounts falling due after more than one year
6
(95,000)
Net assets
195,966
Capital and reserves
Called up share capital
8
131
Share premium account
267,197
Profit and loss reserves
(71,362)
Total equity
195,966

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

For the financial period ended 30 November 2019 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

PREVISICO LIMITED
BALANCE SHEET (CONTINUED)
AS AT 30 NOVEMBER 2019
2019-11-30
- 2 -
The financial statements were approved by the board of directors and authorised for issue on 7 February 2020 and are signed on its behalf by:
Mr J Jackson
Director
Company Registration No. 11663974
PREVISICO LIMITED
STATEMENT OF CHANGES IN EQUITY
FOR THE PERIOD ENDED 30 NOVEMBER 2019
- 3 -
Share capital
Share premium account
Profit and loss reserves
Total
Notes
£
£
£
£
Period ended 30 November 2019:
Loss and total comprehensive income for the period
-
-
(71,362)
(71,362)
Issue of share capital
8
131
267,197
-
267,328
Balance at 30 November 2019
131
267,197
(71,362)
195,966
PREVISICO LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 30 NOVEMBER 2019
- 4 -
1
Accounting policies
Company information

Previsico Limited is a private company limited by shares incorporated in England and Wales. The registered office is Loughborough University, Epinal Way, Loughborough, LE11 3TU.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Going concern

These financial statements are prepared on the going concern basis. The directors have a reasonable expectation that the company will continue in operational existence for the foreseeable future.

1.3
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that it is probable will be recovered.

1.4
Research and development expenditure

Research expenditure is written off against profits in the year in which it is incurred.

1.5
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Fixtures and fittings
25% straight line
Computers
3 years straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

PREVISICO LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 30 NOVEMBER 2019
1
Accounting policies
(Continued)
- 5 -
1.6
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

1.7
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash at bank and in hand only.

1.8
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include trade debtors, corporation tax recoverable, other debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including trade creditors, taxation and social security and other creditors, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.9
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs.

1.10
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

PREVISICO LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 30 NOVEMBER 2019
1
Accounting policies
(Continued)
- 6 -
Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

1.11
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

1.12
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.13
Share-based payments

Equity-settled share-based payments are measured at fair value at the date of grant by reference to the fair value of the equity instruments granted using the Black-Scholes model. The fair value determined at the grant date is expensed on a straight-line basis over the vesting period, based on the estimate of shares that will eventually vest. A corresponding adjustment is made to equity.

1.14
Government grants

Government grants are recognised at the fair value of the asset received or receivable when there is reasonable assurance that the grant conditions will be met and the grants will be received.

 

A grant that specifies performance conditions is recognised in income when the performance conditions are met. Where a grant does not specify performance conditions it is recognised in income when the proceeds are received or receivable. A grant received before the recognition criteria are satisfied is recognised as a liability.

2
Employees

The average monthly number of persons (including directors) employed by the company during the period was 3.

PREVISICO LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 30 NOVEMBER 2019
- 7 -
3
Tangible fixed assets
Plant and machinery etc
£
Cost
At 7 November 2018
-
Additions
5,021
At 30 November 2019
5,021
Depreciation and impairment
At 7 November 2018
-
Depreciation charged in the period
587
At 30 November 2019
587
Carrying amount
At 30 November 2019
4,434
4
Debtors
2019
Amounts falling due within one year:
£
Trade debtors
7,686
Corporation tax recoverable
7,517
Other debtors
33,709
48,912
5
Creditors: amounts falling due within one year
2019
£
Trade creditors
31,837
Taxation and social security
2,569
Other creditors
19,629
54,035
PREVISICO LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 30 NOVEMBER 2019
- 8 -
6
Creditors: amounts falling due after more than one year
2019
£
Other creditors
95,000

On 28 March 2019 the Company received an unsecured loan of £95,000. Interest is to accrue from 28 March 2022 and repayment is due when distributable reserves reach a positive level.

7
Share-based payment transactions
Number of share options
Weighted average exercise price
2019
2019
Number
£
Outstanding at 7 November 2018
-
-
Granted
1,411
0.01
Outstanding at 30 November 2019
1,411
0.01
Exercisable at 30 November 2019
-
-

The options outstanding at 30 November 2019 had an exercise price of £0.01, and a remaining contractual life of 9.67 years.

Inputs were as follows:
2019
Weighted average share price
0.01
Weighted average exercise price
0.01
Expected volatility
50.00
Expected life
10.00
Risk free rate
0.61
8
Called up share capital
2019
£
Ordinary share capital
Issued and fully paid
13,144 Ordinary shares of 1p each
131

On incorporation the company issued 1 ordinary £1 share for a total consideration of £1.00.

On 28 March 2019 the shares were sub-divided into 100 shares with a nominal value of £0.01.

During the period the company issued 13,044 ordinary £0.01 shares for a total consideration of £267,327

2019-11-302018-11-07false07 February 2020CCH SoftwareCCH Accounts Production 2019.301No description of principal activityMr A BaruchDr D YuMr J Jackson116639742018-11-072019-11-30116639742019-11-3011663974core:OtherPropertyPlantEquipment2019-11-3011663974core:CurrentFinancialInstrumentscore:WithinOneYear2019-11-3011663974core:CurrentFinancialInstruments2019-11-3011663974core:Non-currentFinancialInstruments2019-11-3011663974core:ShareCapital2019-11-3011663974core:SharePremium2019-11-3011663974core:RetainedEarningsAccumulatedLosses2019-11-3011663974bus:Director32018-11-072019-11-3011663974core:RetainedEarningsAccumulatedLosses2018-11-072019-11-3011663974core:ShareCapital2018-11-072019-11-3011663974core:SharePremium2018-11-072019-11-3011663974core:FurnitureFittings2018-11-072019-11-3011663974core:ComputerEquipment2018-11-072019-11-3011663974core:OtherPropertyPlantEquipment2018-11-072019-11-3011663974core:WithinOneYear2019-11-3011663974bus:PrivateLimitedCompanyLtd2018-11-072019-11-3011663974bus:SmallCompaniesRegimeForAccounts2018-11-072019-11-3011663974bus:FRS1022018-11-072019-11-3011663974bus:AuditExemptWithAccountantsReport2018-11-072019-11-3011663974bus:Director12018-11-072019-11-3011663974bus:Director22018-11-072019-11-3011663974bus:FullAccounts2018-11-072019-11-30xbrli:purexbrli:sharesiso4217:GBP